CDK9 and familial pancreatic carcinoma: In recent years, Kretz et al. [13] have shown that CDK9 is expressed in pancreatic cancer tissues, and the average overall survival of patients with high CDK9 expression group (10.92 months), which is lower than that of patients with low CDK9 expression group (20.59 months).